Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Alport Syndrome Classification and Management

Kidney Medicine(2020)10.1016/j.xkme.2020.05.014Source: DataRank Database

Alport Syndrome Classification and Management is a research paper published in Kidney Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 98 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access98 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: goldTopics (8)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Rajiv Agarwal ORCID,Sripal Bangalore ORCID,Arlene B. Chapman ORCID,Adeera Levin ORCID,Peter Stenvinkel ORCID

Live enrichment

PubMed:33094278 PMC:PMC7568086

Vertex Pharmaceuticals

Grant: NCT03019185

Bristol-Myers Squibb

Daiichi Sankyo Company

Baxter Healthcare Corporation

National Institutes of Health

Gilead Sciences

Nurses Organization of Veterans Affairs

Amgen

Boehringer Ingelheim

AbbVie

Alport Syndrome Foundation

AstraZeneca

U.S. Department of Veterans Affairs

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.xkme.2020.05.014

publisherhttps://api.elsevier.com/content/article/PII:S2590059520301606?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590059520301606?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7568086

repositoryhttps://doaj.org/article/2c5fd47a1b1c4ef5b389452b3235db65

Keywords

NF-κBNRF2Chronic Kidney DiseaseChronic InflammationAlport SyndromeCol4a3Col4a4Col4a5

Related Papers (5)

Pilot Study of Return of Genetic Results to Patients in Adult Nephrology

Clinical Journal of the American Society of Nephrology(2020)

co-cited

10.2215/cjn.12481019

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

N/A

4.5DataRank · unranked

Kidney International(2022)

co-cited

10.1016/j.kint.2022.03.019

Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals

N/A

1.4DataRank · unranked

JAMA Network Open(2022)

co-cited

10.1001/jamanetworkopen.2022.1048

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

N/A

1.7DataRank · unranked

Journal of the Royal Statistical Society Series B: Statistical Methodology(1995)

co-cited

10.1111/j.2517-6161.1995.tb02031.x

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

N/A

1.6DataRank · unranked

Genetics in Medicine(2015)

co-cited

10.1038/gim.2015.30

Alport Syndrome Classification and Management

FAIR Checklist

Authors (8)

Funding (13 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (5)